SecProbe.io

CORRESP
1
filename1.htm

February
13, 2020

Via
EDGAR

United
States Securities and Exchange Commission

Division
of Corporation Finance, Office of Life Sciences

Mail
Stop 3561

100
F Street, NE

Washington,
D.C. 20549

    Attention:
    Tim
    Buchmiller

    Joseph
    McCann

    Re:
    Quanta,
                                         Inc.

        Registration
        Statement on Form S-1

        Filed
        on January 15, 2020

        File
        No. 333-235930

Ladies
and Gentlemen:

On
behalf of Quanta, Inc., a Nevada corporation (the “Company”), and pursuant to the applicable provisions
of the Securities Act of 1933, as amended (the “Securities Act”), and the rules promulgated thereunder,
we are concurrently filing with the Securities and Exchange Commission (the “Commission”) Amendment
No. 1 to the Company’s Registration Statement on Form S-1 (File No. 333-235930) (the “Registration Statement”),
which was initially filed with the Commission on January 15, 2020. In this letter, we respond to the comment letter from the staff
of the Commission (the “Staff”) to Eric Rice, the Company’s Chief Executive Officer, dated January
27, 2020. The response provided herein is based on information provided to Nelson Mullins Riley & Scarborough LLP by the Company.

The
Staff’s comments are set forth in italics in the numbered paragraphs below, followed by the Company’s responses. Unless
otherwise indicated, capitalized terms used herein have the meanings ascribed to them in the Registration Statement.

Cover
Page

    1.
    We
    note your disclosure on the prospectus cover page that “[t]he Reselling Stockholders may sell all or a portion of the
    shares being offered pursuant to this prospectus at fixed prices and prevailing market prices at the time of sale, at varying
    prices, or at negotiated prices.” Please revise to clarify here and throughout your prospectus that the selling security
    holders will sell the shares of common stock at a fixed price until such time, if ever, as the common stock is quoted on the
    OTC Bulletin Board, the OTCQX, the OCTQB or listed on a securities exchange.

Response:
In response to the Staff’s comment, the Company respectfully advises the Staff that it has revised the Registration
Statement in Amendment No. 1 to clarify on the cover page and throughout the prospectus that the selling security holders will
sell the shares of common stock at a fixed price until such time, if ever, as the common stock is quoted on the OTC Bulletin Board,
the OTCQX, the OCTQB or listed on a securities exchange.

California
| Colorado | District of Columbia | Florida | Georgia | Maryland | Massachusetts | New York

North
Carolina | South Carolina | Tennessee | West Virginia

United
States Securities and Exchange Commission

February
13, 2020

Page 2

Executive
and Director Compensation, page 29

    2.
    Please
    update your filing to include the disclosures required by Regulation S-K Item 402 for your last completed fiscal year.

Response:
In response to the Staff’s comment, the Company respectfully advises the Staff that it has revised the Registration Statement
in Amendment No. 1 to include the disclosures required by Regulation S-K Item 402 for the Company’s last completed fiscal
year.

*
* * * *

United
States Securities and Exchange Commission

February
13, 2020

Page 3

Please
do not hesitate to contact the undersigned at (919) 329-3804 with any questions or comments you may have regarding this letter.

    Sincerely,

     /s/
    W. David Mannheim

    W.
    David Mannheim

cc:
Eric Rice, Chief Executive Officer